Related Experiment Videos
Augmented resting sympathetic activity in awake patients with obstructive sleep apnea
J T Carlson1, J Hedner, M Elam
1Department of Pulmonary Medicine, Reström's Hospital, Goteborg, Sweden.
Chest
|June 1, 1993
Summary
Patients with obstructive sleep apnea (OSA) exhibit elevated muscle sympathetic nerve activity (MSA) and norepinephrine levels during wakefulness. This heightened sympathetic drive may contribute to cardiovascular issues in OSA patients.
Area of Science:
- Cardiovascular Physiology
- Sleep Medicine
- Neuroscience
Background:
- Obstructive sleep apnea (OSA) is linked to cardiovascular complications.
- The role of sympathetic nervous system overactivity in OSA pathophysiology requires further elucidation.
Purpose of the Study:
- To investigate muscle sympathetic nerve activity (MSA) and plasma norepinephrine levels in patients with OSA during wakefulness.
- To explore the relationship between sympathetic activity, blood pressure, and OSA severity.
Main Methods:
- Muscle sympathetic activity (MSA) was recorded in 11 OSA patients and 9 healthy controls.
- Plasma norepinephrine (NE) and neuropeptide Y levels were analyzed.
- Blood pressure and OSA severity metrics (apnea frequency, SaO2) were assessed.
Main Results:
- Resting MSA was significantly higher in OSA patients compared to controls.
- Both arterial and venous plasma norepinephrine levels were elevated in OSA patients.
- Systolic blood pressure positively correlated with resting MSA, but not diastolic BP.
- MSA and plasma NE levels did not correlate with OSA severity (apnea frequency, SaO2).
Conclusions:
- Increased neurogenic sympathetic activity and circulating plasma norepinephrine are present in awake OSA patients.
- This sympathetic overactivity may be an adaptive response to sleep-related hypoxia and hemodynamic changes.
- Elevated sympathetic activity might play a role in the development of cardiovascular complications in OSA.